id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0362-0014,FDA,FDA-2011-N-0362,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-10-04T04:00:00Z,2021,10,2021-10-04T04:00:00Z,,2021-10-04T17:34:21Z,2021-21386,0,0,0900006484db63a6
FDA-2011-N-0362-0013,FDA,FDA-2011-N-0362,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice for Finished Pharmaceuticals, Including Medical Gases, and Active Pharmaceutical Ingredients",Notice,30 Day Proposed Information Collection,2021-06-10T04:00:00Z,2021,6,2021-06-10T04:00:00Z,2021-07-13T03:59:59Z,2021-06-10T13:56:29Z,2021-12214,0,0,0900006484b63b09
FDA-2011-N-0362-0011,FDA,FDA-2011-N-0362,"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice for
Manufacturing, Processing, Packing, and Holding of Finished Pharmaceuticals, Including Medical Gases, and Active Pharmaceutical Ingredients",Notice,60 Day Proposed Information Collection,2021-03-03T05:00:00Z,2021,3,2021-03-03T05:00:00Z,2021-05-04T03:59:59Z,2021-03-16T01:00:15Z,2021-04380,0,0,0900006484a5c7c8